ADMA Biologics, Inc., today announced the opening of its second plasma collection facility in Marietta, Georgia.

"Demand for plasma donation is thriving in the metro Atlanta area and our expansion into the Marietta market is poised for growth," said Cyndi Tolman, VP Plasma Operations.

"This second facility is expected to add additional plasma raw material inventory as we plan for the commercial requirements for our lead product candidate RI-002," stated Adam Grossman, President and Chief Executive Officer. "The current climate is positive for worldwide plasma products growth and industry reports suggest plasma collections are up approximately 9% in 2014." 

The Marietta, GA facility is over 10,000 square feet, and has the potential to support over 50 donor beds at peak capacity. ADMA BioCenters expects to submit a Biologics License Application to the FDA by the end of 2014, which may lead to a potential approval of the center in late 2015 or early 2016, subject to the timing of the FDA's ongoing inspection schedule. This center has the potential to employ over 50 staff members. Plasma donors may be paid as much as $200 per month donating at an ADMA BioCenter. 

Plasma centers provide local economies with financial resources through employment opportunities and compensation to local residents for their plasma donations. Plasma can be used for manufacturing a variety of live saving and life sustaining therapies. For information about plasma donation or to become a donor with ADMA BioCenters, please visit www.atlantaplasma.com.